Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKCI | P41743 | 1/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.54 |
| ▸ | PTPN11 | Q06124 | 2/20 | 0.54 |
| ▸ | BID | P55957 | 6/20 | 0.49 |
| ▸ | MCL1 | Q07820 | 6/20 | 0.49 |
| ▸ | BCL2L1 | Q07817 | 5/20 | 0.49 |
| ▸ | BAK1 | Q16611 | 5/20 | 0.49 |
| ▸ | KAT8 | Q9H7Z6 | 3/20 | 0.49 |
| ▸ | EP300 | Q09472 | 2/20 | 0.49 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.49 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 0.49 |
| ▸ | PPARG | P37231 | 1/20 | 0.49 |
| ▸ | PPARA | Q07869 | 1/20 | 0.49 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.49 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.49 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.43 |
| ▸ | MMP2 | P08253 | 2/20 | 0.42 |
| ▸ | F7 | P08709 | 2/20 | 0.42 |
| ▸ | F3 | P13726 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5194899 | 0.89 | BID (0.58) | PRKCIBIDMCL1BCL2L1BAK1 | |
| SCHEMBL5675080 | 0.88 | BID (0.65) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5676741 | 0.86 | PRKCI (0.46) | PRKCIPTPN1PTPN11BIDMCL1 | |
| SCHEMBL5586821 | 0.86 | BID (0.68) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL5587592 | 0.86 | BID (0.68) | BIDMCL1BCL2L1BAK1KAT8 | |
| SCHEMBL8674815 | 0.85 | PRKCI (0.74) | PRKCIPTPN1PTPN11BIDMCL1 | |
| SCHEMBL5586741 | 0.81 | SELL (0.39) | PRKCIPTPN1PTPN11BIDMCL1 | |
| SCHEMBL5587917 | 0.81 | SELL (0.39) | PRKCIPTPN1PTPN11BIDMCL1 | |
| SCHEMBL5589102 | 0.81 | SELL (0.39) | PRKCIPTPN1PTPN11BIDMCL1 | |
| SCHEMBL5590599 | 0.81 | SELL (0.39) | PRKCIPTPN1PTPN11BIDMCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4114960-A2 | PRENYLTRANSFERASES AND METHODS OF MAKING AND USE THEREOF | Cellibre, Inc. (US) | 2023-01-11 | — | — | EP | disclosed |
| WO-2021178976-A2 | PRENYLTRANSFERASES AND METHODS OF MAKING AND USE THEREOF | CELLIBRE, INC. (US) | 2021-09-10 | — | — | WO | disclosed |
| WO-2019053541-A1 | ACRYLATES THROUGH OLEFIN/CARBON DIOXIDE COUPLING | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2019-03-21 | — | — | WO | disclosed |
| WO-2019053540-A1 | METHODS OF PRODUCING ALPHA, BETA-UNSATURATED CARBOXYLIC ACID SALTS FROM ALKANES AND CARBON DIOXIDE | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2019-03-21 | — | — | WO | disclosed |
| WO-2017158469-A1 | METHODS OF MAKING ALPHA, BETA-UNSATURATED CARBOXYLIC ACIDS OR SALTS | SABIC GLOBAL TECHNOLOGIES B.V. (NL) | 2017-09-21 | — | — | WO | disclosed |
| EP-1620447-B1 | SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III | EXXONMOBIL CHEM PATENTS INC (US) | 2007-08-08 | — | — | EP | disclosed |
| US-7067450-B2 | Soluble late transition metal catalysts for olefin oligomerizations III | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-06-27 | — | — | US | disclosed |
| US-20060036049-A1 | Soluble late transition metal catalysts for olefin oligomerizations III | ZHAO BAIYI | 2006-02-16 | — | — | US | disclosed |
| EP-1620447-A1 | SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III | Exxonmobil Chemical Patents Inc. (US) | 2006-02-01 | — | — | EP | disclosed |
| EP-1521758-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | Exxonmobil Chemical Patents Inc. (US) | 2005-04-13 | — | — | EP | disclosed |
| US-20040044150-A1 | Soluble late transition metal catalysts for olefin oligomerizations III | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-03-04 | — | — | US | disclosed |
| WO-2004007509-A1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2004-01-22 | — | — | WO | disclosed |
| WO-2003102006-A1 | SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2003-12-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060036049-A1 | Soluble late transition metal catalysts for olefin oligomerizations III | COMT, CD69, SPR | PRKCI 4096/4885PTPN1 4673/4885PTPN11 4670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.